1. Home
  2. LCNB vs ELDN Comparison

LCNB vs ELDN Comparison

Compare LCNB & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LCNB

LCNB Corporation

HOLD

Current Price

$16.95

Market Cap

229.7M

Sector

Finance

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.10

Market Cap

235.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
ELDN
Founded
1877
2004
Country
United States
United States
Employees
N/A
33
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
235.1M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
LCNB
ELDN
Price
$16.95
$3.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
29.1K
1.3M
Earning Date
04-23-2026
05-13-2026
Dividend Yield
5.12%
N/A
EPS Growth
68.04
30.67
EPS
1.63
N/A
Revenue
$6,445,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
$10.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.56
$1.35
52 Week High
$17.89
$4.60

Technical Indicators

Market Signals
Indicator
LCNB
ELDN
Relative Strength Index (RSI) 62.62 59.62
Support Level $17.08 $2.45
Resistance Level $17.79 $3.17
Average True Range (ATR) 0.41 0.20
MACD 0.21 -0.01
Stochastic Oscillator 89.43 70.00

Price Performance

Historical Comparison
LCNB
ELDN

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: